Paid Clinical Trials in Amherst, NY
As of August 2026, 36 paid clinical trials are recruiting in Amherst, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Amherst offers studies at sites including Dent Neurologic Institute for conditions such as Migraine, Chronic Migraine, AChR-Ab Seropositive Generalized Myasthenia Gravis, Episodic Migraine. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Amherst
Trials by drug in Amherst
Filter results
Newly added in Amherst
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
29 clinical trials
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Study of EVO756 in Adults With Migraine
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Clinical Trial on Agitation in Alzheimer's Dementia
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Responding With Evidence and Access for Childhood Headaches
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Top Research Study Locations in Amherst
Researchers run research studies in Amherst, NY at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dent Neurologic Institute | Obesity, Overweight, Aggression | 7 |
| Dent Neurologic Institute - Amherst | AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis, Generalized Myasthenia Gravis (gMG) | 7 |
| Dent Neurosciences Research Center | Focal Epilepsy, Acute Treatment of Migraine, Pediatric Migraine | 4 |
| Dent Neurological Institute | Chronic Migraine, Headache, Headache Disorders | 3 |
| Dent Neuro Institute, Buffalo | Acute Migraine, Migraine | 2 |
| Dent Neurosciences Research Center, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| A12 | Myasthaenia Gravis | 1 |
| Amherst Surgery Center | Lumbar Spinal Stenosis | 1 |
| Clinosis - Dent Neurologic Instite | Migraine | 1 |
| Dent Neurosciences Research Center, Inc | Alzheimer's Disease | 1 |
| Dent Neurosciences Research Center, Inc. | Migraine Prophylaxis | 1 |
| Ep0165 50497 | Stereotypical Prolonged Seizures | 1 |
| Mg0038 10106 | Ocular Myasthenia Gravis | 1 |
| Praxis Research Site | Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
| University at Buffalo | Head Injuries | 1 |
Active & Upcoming Studies in Amherst (2026)
Recruiting trials in Amherst grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Neurology & pain (19 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (3 active studies)
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
- Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems · RxFunction Inc.
Mental health & behavior (2 active studies)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
- A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression · LivaNova
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Amherst
- Migraine (5 active studies)
- Chronic Migraine (3 active studies)
- AChR-Ab Seropositive Generalized Myasthenia Gravis (2 active studies)
- Episodic Migraine (2 active studies)
- Focal Epilepsy (2 active studies)
- Generalized Myasthenia Gravis (2 active studies)
Leading research sponsors in Amherst
- AbbVie
- Biohaven Therapeutics Ltd.
- Eli Lilly and Company
- Kallyope Inc.
- Merz Therapeutics GmbH
Frequently asked questions
How many paid clinical trials are currently recruiting in Amherst?
There are approximately 36 recruiting clinical trials in Amherst, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Amherst pay participants?
Most recruiting trials in Amherst compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Amherst?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Amherst?
The most common conditions under active study in Amherst include Migraine (5), Chronic Migraine (3), AChR-Ab Seropositive Generalized Myasthenia Gravis (2), Episodic Migraine (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Amherst?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Amherst on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Amherst?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Amherst?
Recruiting research sites in Amherst include Dent Neurologic Institute, Dent Neurologic Institute - Amherst, Dent Neurosciences Research Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Amherst right now?
The largest active categories in Amherst are Neurology & pain (19), Diabetes & metabolic (3), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.